Use of pharmaceutical nanotechnology for the treatment of leishmaniasis

Rev Soc Bras Med Trop. 2019 Apr 11:52:e20180246. doi: 10.1590/0037-8682-0246-2018.
[Article in Portuguese]

Abstract

Introduction: Leishmaniasis is a global public health concern. Currently available treatments are associated with considerable side effects. The use of nanotechnology has shown promise for improving efficacy and bioavailability and minimizing side effects.

Methods: This study investigated available literature, including patents and scientific articles, to identify advances in the use of nanotechnology for the treatment of leishmaniasis.

Results: Our findings revealed a stable number of patents and scientific articles published over the past five years.

Conclusions: There is a need to intensify research on the use of nanotechnology for the treatment of leishmaniasis.

MeSH terms

  • Antiprotozoal Agents / administration & dosage*
  • Bibliometrics
  • Biomedical Research / statistics & numerical data*
  • Humans
  • Leishmaniasis / drug therapy*
  • Nanotechnology / statistics & numerical data*
  • Patents as Topic / statistics & numerical data

Substances

  • Antiprotozoal Agents